Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Role of CYP2B6 Polymorphisms in Ketamine Metabolism and Clearance


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01988922

Organisation Name: Washington University School of Medicine

Overal Status: Completed

Start Date: November 2013

Last Update: May 18, 2018

Lead Sponsor: Washington University School of Medicine

Brief Summary: This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes ketamine.

Conditions:
  • Healthy Volunteers


Total execution time in seconds: 0.15941596031189